NCT01431313View on ClinicalTrials.gov

Inhaled Nitrite in Subjects With Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Pulmonary HypertensionHeart Failure, Diastolic
Interventions
DRUG

Inhaled Nitrite

Each patient will receive a starting dose of 45 mg of inhaled nitrite, with one planned subsequent planned dose of 90 mg of inhaled nitrite

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

Schmidhofer, Mark, MD

INDIV

NCT01431313 - Inhaled Nitrite in Subjects With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter